Energy Production and Metabolism — MCQs

A scientist was studying the electron transport chain and developed a compound that bound to all the cytochromes in the proteins of the electron transport chain. Once bound, the compound blocked electron acceptance by the iron in the heme group of the cytochrome. Which one of the following would be most likely to occur in the presence of an oxidizable substrate?

Q129Easy

All of the following participate in oxidative phosphorylation except?

Q130Easy

Which cell in the body primarily utilizes the pentose phosphate pathway?

Energy Production and Metabolism Indian Medical PG Practice Questions and MCQs

Question 121: Which of the following hormones can cause hyperglycemia without known effects on glycogen or gluconeogenesis?

A. Thyroxine (Correct Answer)
B. Epinephrine
C. Glucocorticoids
D. Epidermal growth factor

Explanation: **Explanation:** The correct answer is **Thyroxine (T4)**. While most "anti-insulin" hormones increase blood glucose by stimulating glycogenolysis or gluconeogenesis, Thyroxine has a unique primary mechanism for inducing hyperglycemia. **1. Why Thyroxine is Correct:** Thyroxine increases blood glucose levels primarily by **increasing the rate of glucose absorption from the gastrointestinal tract**. While it does have some permissive effects on catecholamines, its direct and most distinct hyperglycemic action—independent of hepatic glucose production pathways—is the acceleration of intestinal hexose transport. **2. Why the Other Options are Incorrect:** * **Epinephrine:** This is a potent stimulator of **glycogenolysis** in both the liver (increasing blood glucose) and muscle (increasing lactate). It also stimulates gluconeogenesis. * **Glucocorticoids (e.g., Cortisol):** These are classic "diabetogenic" hormones that primarily increase blood glucose by inducing the synthesis of key enzymes involved in **gluconeogenesis** (e.g., PEPCK) and by decreasing peripheral glucose uptake. * **Epidermal Growth Factor (EGF):** This is a signaling protein involved in cell growth and proliferation; it does not play a primary or significant role in systemic glucose homeostasis. **3. NEET-PG High-Yield Pearls:** * **Hyperthyroidism & Diabetes:** Patients with hyperthyroidism often show abnormal glucose tolerance tests (GTT) because the rapid absorption of glucose leads to a high postprandial peak (lag storage curve). * **Growth Hormone:** Also causes hyperglycemia by decreasing peripheral glucose utilization (anti-insulin effect). * **Glucagon:** The primary hormone for acute glucose elevation via hepatic glycogenolysis and gluconeogenesis. * **Key Enzyme:** Glucocorticoids increase the expression of **Glucose-6-Phosphatase**, the final common enzyme for both gluconeogenesis and glycogenolysis.

Question 122: Which of the following is considered the regulated step in steroid hormone synthesis in the zona fasciculata?

A. Cholesterol to pregnenolone (Correct Answer)
B. Corticosterone to aldosterone
C. 11-Deoxycortisol to cortisol
D. Pregnenolone to progesterone

Explanation: ### **Explanation** The conversion of **cholesterol to pregnenolone** is the **rate-limiting and primary regulated step** in the biosynthesis of all steroid hormones, including those produced in the zona fasciculata (cortisol). **1. Why Option A is Correct:** This reaction occurs within the mitochondria and is catalyzed by the enzyme **Cholesterol Side-Chain Cleavage enzyme (P450scc / CYP11A1)**. The regulation occurs via the **Steroidogenic Acute Regulatory (StAR) protein**, which transports cholesterol from the outer to the inner mitochondrial membrane. In the zona fasciculata, this step is stimulated by **ACTH** (Adrenocorticotropic hormone), which increases cAMP levels to activate StAR and P450scc. **2. Why the Other Options are Incorrect:** * **Option B (Corticosterone to aldosterone):** This is the final step of mineralocorticoid synthesis, catalyzed by Aldosterone Synthase. It is the regulated step in the **zona glomerulosa** (stimulated by Angiotensin II), not the zona fasciculata. * **Option C (11-Deoxycortisol to cortisol):** This is the final step of cortisol synthesis catalyzed by 11β-hydroxylase. While essential, it is not the primary rate-limiting regulatory point. * **Option D (Pregnenolone to progesterone):** This reaction is catalyzed by 3β-hydroxysteroid dehydrogenase. It is a common intermediate step but does not serve as the primary flux-control point. ### **High-Yield NEET-PG Pearls:** * **Rate-limiting enzyme:** Cholesterol side-chain cleavage enzyme (P450scc/Desmolase). * **Rate-limiting protein:** StAR protein (transports cholesterol). * **Location:** The conversion of cholesterol to pregnenolone happens in the **mitochondria**; subsequent steps occur in the **Smooth Endoplasmic Reticulum (SER)**. * **Congenital Adrenal Hyperplasia (CAH):** The most common enzyme deficiency is **21-hydroxylase**, but a deficiency in the StAR protein leads to **Congenital Lipoid Adrenal Hyperplasia** (the most severe form).

Question 123: How many ATP molecules are generated in the Krebs cycle?

A. 12
B. 24 (Correct Answer)
C. 15
D. 30

Explanation: **Explanation:** The Krebs cycle (TCA cycle) is the final common pathway for the oxidation of carbohydrates, lipids, and proteins. To understand why **24 ATP** is the correct answer, we must calculate the yield per molecule of **Glucose**. 1. **Per Turn of the Cycle:** One molecule of Acetyl-CoA entering the cycle generates: * 3 NADH (3 × 2.5 = 7.5 ATP) * 1 FADH₂ (1 × 1.5 = 1.5 ATP) * 1 GTP/ATP (Substrate-level phosphorylation) * **Total per Acetyl-CoA = 10 ATP** (Modern yield) or **12 ATP** (Classic yield). 2. **Per Glucose Molecule:** One glucose molecule produces **two** Acetyl-CoA molecules via glycolysis and the pyruvate dehydrogenase complex. Therefore, the cycle turns twice per glucose. * **12 ATP × 2 = 24 ATP.** **Analysis of Options:** * **Option A (12):** This represents the ATP yield for a **single turn** of the cycle (one Acetyl-CoA). * **Option B (24):** Correct. It represents the total yield from the Krebs cycle for **one glucose molecule** (two turns). * **Option C (15):** This is the yield of one pyruvate molecule being completely oxidized to CO₂ and H₂O (Pyruvate to Acetyl-CoA = 3 ATP + Krebs cycle = 12 ATP). * **Option D (30):** This is the total net ATP yield of the **entire aerobic respiration** process (Glycolysis + Link Reaction + Krebs Cycle) using modern shuttle calculations. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Isocitrate Dehydrogenase. * **Substrate-level phosphorylation:** Occurs at the step of **Succinate Thiokinase** (Succinyl-CoA to Succinate). * **Inhibitors:** Fluoroacetate (inhibits Aconitase), Arsenite (inhibits α-ketoglutarate dehydrogenase), and Malonate (competitive inhibitor of Succinate dehydrogenase). * **Amphibolic nature:** The TCA cycle serves both catabolic (energy production) and anabolic (providing precursors for amino acids and heme) functions.

Question 124: In oxidative phosphorylation, the oxidation of one NADH to NAD+ produces how many ATPs?

A. 5
B. 6
C. 4
D. 3 (Correct Answer)

Explanation: **Explanation:** In oxidative phosphorylation, the oxidation of **NADH** occurs via the Electron Transport Chain (ETC). NADH enters the chain at **Complex I** (NADH dehydrogenase). As electrons pass from NADH through the ETC to oxygen, protons are pumped from the mitochondrial matrix into the intermembrane space at three specific sites: * **Complex I:** 4 protons * **Complex III:** 4 protons * **Complex IV:** 2 protons This creates a total gradient of **10 protons** per NADH molecule. According to the classical P:O ratio (used in most standard medical textbooks like Harper’s and Lehninger for competitive exams), it takes approximately 3 protons to drive the ATP synthase and 1 proton for phosphate transport. Thus, 10 protons yield approximately **3 ATPs**. (Note: While modern research suggests a more precise value of 2.5, the traditional value of 3 remains the standard for NEET-PG unless 2.5 is specifically provided as an option). **Analysis of Incorrect Options:** * **Options A & B (5 and 6):** These values are physiologically impossible for a single NADH molecule as the proton gradient generated is insufficient to drive the synthesis of this many ATP molecules. * **Option C (4):** This value is incorrect because the energy released during the transfer of electrons from NADH to Oxygen is only sufficient to pump 10 protons, which correlates to 3 ATPs. **High-Yield Clinical Pearls for NEET-PG:** * **FADH2** enters at **Complex II**, bypassing the first proton pump. It results in the pumping of only 6 protons, yielding **2 ATPs** (Modern value: 1.5). * **Cyanide and Carbon Monoxide** inhibit **Complex IV** (Cytochrome c oxidase), halting ATP production. * **Oligomycin** directly inhibits the **F0 subunit** of ATP synthase. * **Uncouplers** (e.g., 2,4-DNP, Thermogenin) increase oxygen consumption but decrease ATP synthesis by dissipating the proton gradient as heat.

Question 125: In the electron transport chain (ETC), oxidative phosphorylation (ATP formation) is regulated by which of the following components?

A. NADH Co-Q reductase
B. Cytochrome C oxidase
C. Co-Q-Cytochrome C reductase
D. All of the above (Correct Answer)

Explanation: **Explanation:** Oxidative phosphorylation is the process where ATP is synthesized as a result of electron transfer from NADH or FADH₂ to O₂ by a series of electron carriers. The regulation of this process is tightly coupled to the electron transport chain (ETC) through **respiratory control**. **1. Why "All of the above" is correct:** The rate of ATP formation is regulated by the rate of electron flow through the ETC. There are three primary sites in the chain where the change in free energy is large enough to drive ATP synthesis. These sites are the regulatory "checkpoints" of the chain: * **Complex I (NADH Co-Q reductase):** The entry point for electrons from NADH. * **Complex III (Co-Q-Cytochrome C reductase):** Facilitates the Q-cycle. * **Complex IV (Cytochrome C oxidase):** The final step where oxygen is reduced to water. Because electron flow must pass through all these complexes to maintain the proton gradient required by ATP synthase (Complex V), any of these components can act as a regulatory site. If the activity of any of these complexes is altered (by substrate availability or inhibitors), the rate of oxidative phosphorylation is directly affected. **2. Analysis of Options:** * **Options A, B, and C** are all correct individually because they represent the three coupling sites (Sites I, II, and III of phosphorylation) where the energy released is sufficient to pump protons ($H^+$) across the inner mitochondrial membrane. Therefore, the most comprehensive answer is **Option D**. **High-Yield Clinical Pearls for NEET-PG:** * **Complex II (Succinate Dehydrogenase):** It is the only complex that **does not** pump protons and is therefore not a site for ATP regulation/formation. * **Inhibitors (High Yield):** * Complex I: Rotenone, Amobarbital. * Complex III: Antimycin A. * Complex IV: Cyanide, Carbon Monoxide (CO), Azide. * Complex V (ATP Synthase): Oligomycin. * **Uncouplers:** (e.g., 2,4-DNP, Thermogenin) Dissipate the proton gradient, allowing ETC to continue but stopping ATP synthesis, leading to heat production.

Question 126: In the TCA cycle, from which molecule is CO2 released?

A. Thiokinase
B. Isocitrate dehydrogenase (Correct Answer)
C. Citrate dehydrogenase
D. Alpha ketoglutarate

Explanation: **Explanation:** In the Tricarboxylic Acid (TCA) cycle, carbon dioxide ($CO_2$) is released during **oxidative decarboxylation** reactions. The correct answer is **Isocitrate dehydrogenase**, which catalyzes the conversion of Isocitrate to $\alpha$-Ketoglutarate. This is the first rate-limiting step where $CO_2$ is produced and $NAD^+$ is reduced to $NADH + H^+$. **Analysis of Options:** * **Isocitrate Dehydrogenase (Correct):** It facilitates the decarboxylation of the 6-carbon isocitrate into the 5-carbon $\alpha$-ketoglutarate. * **Thiokinase (Incorrect):** Also known as Succinyl-CoA synthetase, this enzyme converts Succinyl-CoA to Succinate. It is responsible for **substrate-level phosphorylation** (generating GTP/ATP), not $CO_2$ release. * **Citrate Dehydrogenase (Incorrect):** This is a distractor; there is no enzyme by this name in the TCA cycle. Citrate is formed by Citrate Synthase. * **Alpha-ketoglutarate (Incorrect):** This is a *substrate*, not an enzyme. While the enzyme $\alpha$-ketoglutarate dehydrogenase does release $CO_2$, the option lists the molecule itself. **High-Yield NEET-PG Pearls:** 1. **Two $CO_2$ Exit Points:** $CO_2$ is released at two steps in the TCA cycle: * Isocitrate $\rightarrow$ $\alpha$-Ketoglutarate (via Isocitrate Dehydrogenase). * $\alpha$-Ketoglutarate $\rightarrow$ Succinyl-CoA (via $\alpha$-Ketoglutarate Dehydrogenase). 2. **Rate-Limiting Step:** Isocitrate dehydrogenase is the primary rate-limiting enzyme of the TCA cycle, inhibited by high ATP and NADH. 3. **Cofactors:** $\alpha$-Ketoglutarate dehydrogenase requires five cofactors (Tender Loving Care For No-one): **T**PP, **L**ipoic acid, **C**oA, **F**AD, and **N**AD.

Question 127: Which of the following is an uncoupler of oxidative phosphorylation?

A. 2, 4-Dinitrophenol (2,4-DNP) (Correct Answer)
B. British Anti-Lewisite (BAL)
C. Trientine
D. Rotenone

Explanation: ### Explanation **Correct Option: A. 2, 4-Dinitrophenol (2,4-DNP)** Uncouplers are substances that dissociate oxidation from phosphorylation. They act by increasing the permeability of the inner mitochondrial membrane to protons ($H^+$). This collapses the proton gradient, allowing electrons to flow through the Electron Transport Chain (ETC) to oxygen without the synthesis of ATP. The energy released is dissipated as **heat**. 2,4-DNP is a classic lipophilic protonophore that carries protons across the membrane, bypassing the $F_0F_1$ ATP synthase. **Analysis of Incorrect Options:** * **B. British Anti-Lewisite (BAL):** Also known as Dimercaprol, this is a chelating agent used in heavy metal poisoning (e.g., arsenic, mercury). In the context of the ETC, it acts as an **inhibitor of Complex III**, not an uncoupler. * **C. Trientine:** This is a chelating agent specifically used to treat **Wilson’s Disease** by removing excess copper. It has no direct role in the inhibition or uncoupling of oxidative phosphorylation. * **D. Rotenone:** This is a classic **inhibitor of Complex I** (NADH dehydrogenase). It blocks the transfer of electrons from Fe-S centers to Ubiquinone, halting the entire respiratory chain. **High-Yield Clinical Pearls for NEET-PG:** * **Physiological Uncoupler:** **Thermogenin (UCP1)** found in brown adipose tissue is essential for non-shivering thermogenesis in neonates. * **Other Uncouplers:** High doses of **Salicylates** (Aspirin), Dicumarol, and FCCP. * **Clinical Presentation:** Uncoupler overdose leads to hyperthermia, tachycardia, and diaphoresis because energy is lost as heat instead of being stored as ATP. * **Key Distinction:** Inhibitors (like Cyanide or Rotenone) stop oxygen consumption; Uncouplers **increase** oxygen consumption while stopping ATP synthesis.

Question 128: A scientist was studying the electron transport chain and developed a compound that bound to all the cytochromes in the proteins of the electron transport chain. Once bound, the compound blocked electron acceptance by the iron in the heme group of the cytochrome. Which one of the following would be most likely to occur in the presence of an oxidizable substrate?

A. The amount of heat generated from NADH oxidation would increase.
B. The rate of succinate oxidation would not be affected.
C. ATP could still be generated from the oxidation of NADH by transfer of electrons to O2.
D. Cell death would result from a lack of ATP. (Correct Answer)

Explanation: ### Explanation **Core Concept: Electron Transport Chain (ETC) Inhibition** The Electron Transport Chain (ETC) consists of a series of protein complexes (I-IV) that transfer electrons from donors (NADH, $FADH_2$) to a final acceptor (Oxygen). Cytochromes (containing heme iron) are essential components of Complexes III and IV. If a compound blocks the iron in these cytochromes from accepting electrons, the entire flow of electrons is halted. This prevents the establishment of a proton gradient across the inner mitochondrial membrane, leading to the complete cessation of oxidative phosphorylation (ATP synthesis). Since most cells rely on aerobic respiration for energy, a total lack of ATP leads to rapid cellular dysfunction and death. **Analysis of Options:** * **Option A (Incorrect):** Heat generation from NADH oxidation occurs when the ETC is "uncoupled" (e.g., via Thermogenin). However, if the cytochromes are blocked, electron flow stops entirely; therefore, no energy (neither ATP nor heat) can be released from NADH oxidation. * **Option B (Incorrect):** Succinate is oxidized by Complex II (Succinate Dehydrogenase). Electrons from Complex II must pass through Cytochrome $b$ and $c_1$ (Complex III) and Cytochromes $a$ and $a_3$ (Complex IV) to reach Oxygen. Blocking these cytochromes will stop succinate oxidation. * **Option C (Incorrect):** ATP generation requires the transfer of electrons to $O_2$ through the cytochromes. If this pathway is blocked, no ATP can be produced via the ETC. * **Option D (Correct):** Without ATP, vital cellular processes (like the $Na^+/K^+$ ATPase pump) fail, leading to osmotic swelling and cell death. **NEET-PG High-Yield Pearls:** * **Complex IV Inhibitors:** Cyanide ($CN^-$), Carbon Monoxide (CO), and Hydrogen Sulfide ($H_2S$) bind to the $Fe^{3+}$ or $Fe^{2+}$ in Cytochrome $aa_3$, mimicking the mechanism described in the question. * **Antimycin A:** Specifically inhibits Complex III (Cytochrome $bc_1$ complex). * **Rotenone & Amytal:** Inhibit Complex I. * **Oligomycin:** Inhibits the $F_0$ subunit of ATP synthase, stopping both ATP synthesis and electron flow (respiratory control).

Question 129: All of the following participate in oxidative phosphorylation except?

A. NADH (Correct Answer)
B. FADH2
C. NADPH
D. ATP

Explanation: **Explanation:** The question asks for the molecule that does **not** participate in oxidative phosphorylation. While the provided answer key indicates NADH, there appears to be a conceptual nuance or potential error in the key provided, as **NADPH (Option C)** is the physiologically correct answer for "not participating" in the Electron Transport Chain (ETC). However, based on the provided key: **1. Why NADH is the marked answer:** In the context of some specific examination patterns, the question may be interpreted as "which molecule is the *starting substrate* vs. a *component* of the machinery." However, biochemically, **NADPH** is the correct outlier. NADPH is primarily used for **reductive biosynthesis** (fatty acid/steroid synthesis) and maintaining antioxidant defenses (glutathione reduction) in the cytoplasm, rather than donating electrons to the mitochondrial ETC for ATP production. **2. Analysis of Options:** * **NADH (Option A):** The primary electron donor for Complex I. It is essential for oxidative phosphorylation. * **FADH2 (Option B):** The electron donor for Complex II (Succinate dehydrogenase). It is essential for oxidative phosphorylation. * **ATP (Option D):** The end product of the process, synthesized by Complex V (ATP Synthase) using the proton gradient. It is an integral participant in the phosphorylation aspect of the process. * **NADPH (Option C):** Does not donate electrons to the ETC. It is sequestered for anabolic pathways. **3. High-Yield Clinical Pearls for NEET-PG:** * **P/O Ratio:** NADH produces ~2.5 ATP; FADH2 produces ~1.5 ATP. * **Inhibitors:** Know the "Big Four": Complex I (Rotenone), Complex III (Antimycin A), Complex IV (Cyanide/CO), and Complex V (Oligomycin). * **Uncouplers:** 2,4-DNP and Thermogenin (brown fat) dissipate the proton gradient as heat, bypassing ATP synthesis. * **Shuttles:** Since NADH cannot cross the mitochondrial membrane, it uses the **Malate-Aspartate shuttle** (heart/liver) or **Glycerol-3-Phosphate shuttle** (muscle/brain).

Question 130: Which cell in the body primarily utilizes the pentose phosphate pathway?

A. Red Blood Cells (RBCs) (Correct Answer)
B. Hepatocytes
C. Muscle cells
D. Neurons

Explanation: The Pentose Phosphate Pathway (PPP), also known as the Hexose Monophosphate (HMP) Shunt, is the primary source of **NADPH** in the body. **Why Red Blood Cells (RBCs) are the correct answer:** RBCs are uniquely dependent on the PPP because they lack mitochondria. The PPP is their **only source of NADPH**. NADPH is essential for maintaining a pool of **reduced glutathione**, which neutralizes reactive oxygen species (ROS) like hydrogen peroxide. Without this pathway, hemoglobin would undergo oxidative damage, leading to the formation of Heinz bodies and subsequent hemolysis. **Analysis of Incorrect Options:** * **Hepatocytes:** While the liver is a major site for the PPP (used for fatty acid and cholesterol synthesis), hepatocytes have alternative metabolic pathways and mitochondria to manage oxidative stress. * **Muscle cells:** Muscles primarily utilize glucose for ATP production via glycolysis and the TCA cycle. They have very low PPP activity because they do not perform significant lipid synthesis. * **Neurons:** Neurons rely almost exclusively on aerobic glycolysis and the TCA cycle for high energy demands. While they use some NADPH for antioxidant defense, it is not their primary metabolic characteristic compared to RBCs. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Glucose-6-Phosphate Dehydrogenase (G6PD). * **G6PD Deficiency:** The most common enzymopathy worldwide. It leads to neonatal jaundice and drug-induced hemolytic anemia (e.g., after taking Primaquine or eating Fava beans) due to the inability of RBCs to produce NADPH. * **Tissues with high PPP activity:** Adrenal cortex, Liver, Testes/Ovaries (for steroid synthesis), and Lactating mammary glands (for fatty acid synthesis). * **Products:** NADPH (for reductive biosynthesis) and Ribose-5-phosphate (for nucleotide synthesis).

Practice by Chapter

Bioenergetics and Thermodynamics

Practice Questions

ATP as Energy Currency

Practice Questions

Tricarboxylic Acid Cycle

Practice Questions

Electron Transport Chain

Practice Questions

Oxidative Phosphorylation

Practice Questions

Mitochondrial Diseases

Practice Questions

Uncouplers and Inhibitors of Oxidative Phosphorylation

Practice Questions

Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate

Practice Questions

Energy Yield from Nutrients

Practice Questions

Metabolic Rate and Basal Metabolism

Practice Questions

Brown Adipose Tissue and Thermogenesis

Practice Questions

Oxygen Toxicity and Free Radicals

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free